Cargando…
Chemokine blockade: a new era in the treatment of rheumatoid arthritis?
Blockade of chemokines or chemokine receptors is emerging as a new potential treatment for various immune-mediated conditions. This review focuses on the therapeutic potential in rheumatoid arthritis, based on studies in animal models and patients. Several knockout models as well as in vivo use of c...
Autores principales: | Haringman, Jasper J, Tak, Paul P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC416447/ https://www.ncbi.nlm.nih.gov/pubmed/15142257 http://dx.doi.org/10.1186/ar1172 |
Ejemplares similares
-
Chemokine blockade in patients with rheumatoid arthritis: reduction of synovial inflammation
por: Haringman, JJ, et al.
Publicado: (2002) -
Expression of chemokines and their receptors in synovial tissue of patients with rheumatoid arthritis, osteoarthritis and reactive arthritis
por: Haringman, JJ, et al.
Publicado: (2003) -
IL-20 is expressed in inflamed synovium of patients with psoriatic arthritis and rheumatoid arthritis
por: Smeets, TJM, et al.
Publicado: (2004) -
The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)
por: Kraan, Maarten C, et al.
Publicado: (2001) -
Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis
por: Haringman, Jasper J, et al.
Publicado: (2005)